Fed's Kashkari:May be appropriate in the near term to adjust policy rate

Pharma stocks tumble as Trump hints at 250% tariffs; Nasdaq drops. Traders eye global trade risks.

US slaps 39% tariff on Swiss cheese! Gruyere exports may drop 1k tons, costing $18.6M. Producers brace for impact.

GLW surges 67% YTD, beating SPX & XLK! Q2 EPS $0.60, sales $4.05B on AI demand. Analysts see 24.5% EPS growth.

IDXX surges 59.4% YTD, beating NVDA/MSFT! Q2 earnings up 49%, but valuation metrics are sky-high. Analysts rate it a Moderate Buy.

Bybit eyes EU derivatives license, ditches MT5 for in-house TraFi. 74M users, $1.5B hack fallout.

US tariffs near 22%, unlikely to lift on key sectors. JPMorgan warns against expecting pre-2017 trade policy return.

Kroger (KR) surges 17.3% YTD, outperforming S&P 500. Analysts see 7.1% upside with a 'Moderate Buy' rating.